AbCellera
An experienced Principal Scientist will lead the planning, design, execution, and interpretation of non‑GLP and GLP toxicology studies to support IND, CTA, and BLA submissions. The role serves as the primary scientific interface with CROs and cross‑functional teams, providing risk‑benefit assessments and contributing to regulatory documents.
Headquarters
Vancouver, British Columbia, Canada
Company Size
501-1000 employees
Founded
2012
AbCellera is a biotechnology company that discovers and develops therapeutic antibodies using a proprietary high-throughput single‑cell screening platform combined with machine learning and large immune datasets. It partners with pharma and biotech to rapidly identify and optimize antibody leads and also advances its own pipeline of first‑in‑class and best‑in‑class programs across multiple indications and modalities. The platform is designed to accelerate target‑to‑candidate timelines and has been used in rapid-response collaborations and clinical‑stage antibody programs.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AbCellera.
AbCellera didn’t post a salary, so this is our estimate from similar listings.
42% above the average for this role
We're Not Worried About AbCellera Biologics' (NASDAQ:ABCL) Cash Burn
Dec 25, 2025
Director, Toxicology Translational Science
Tarsus Pharmaceuticals
Director/Senior Director, Nonclinical Safety
Nimbus Therapeutics
Sr. Scientist II, Toxicology
oraclecloudinfrastructure
Director, Toxicology
Praxis Precision Medicines, Inc.
Director, Toxicology Translational Science
Tarsus Pharmaceuticals
Senior Director, Toxicology
Disc Medicine